Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alibaba Health Information Technology ( (HK:0241) ) has shared an update.
Alibaba Health Information Technology has granted 3,881,600 restricted share units to 20 employees under its 2024 Share Award Scheme, with each unit representing the right to receive one share upon vesting. The awards, which carry no purchase price and are based on a grant-date share price of HK$5.02, will vest in batches over four years, with certain tranches vesting within 12 months in line with scheme rules, reinforcing employee incentives and aligning staff interests with long-term shareholder value.
None of the recipients are directors or senior management, indicating the scheme’s focus on broader employee retention and motivation across the group’s workforce. The board and remuneration committee retain discretion over vesting terms, within a minimum 12‑month framework and specific permitted exceptions, giving the company flexibility to tailor equity-based compensation to operational needs and talent management priorities.
The most recent analyst rating on (HK:0241) stock is a Buy with a HK$6.00 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited is a Bermuda-incorporated company listed in Hong Kong that operates in the healthcare and health-technology sector. It focuses on providing healthcare-related services and solutions within the broader Alibaba ecosystem, targeting consumers and healthcare stakeholders in the Greater China market.
Average Trading Volume: 130,557,347
Technical Sentiment Signal: Sell
Current Market Cap: HK$82.47B
See more data about 0241 stock on TipRanks’ Stock Analysis page.